Dow Up 0.26% Nasdaq Down 1.07%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
2.50 Down 0.11(4.21%) 4:00PM EDT
|After Hours : 2.50 0.00 (0.00%) 5:16PM EDT
Prev Close:2.61
Open:2.62
Bid:2.50 x 1000
Ask:6.99 x 100
1y Target Est:5.08
Beta:1.64
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:2.48 - 2.62
52wk Range:1.21 - 4.25
Volume:921,856
Avg Vol (3m):1,171,740
Market Cap:361.13M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CTIC

Comparison

Symbol% ChgMkt Cap
CTICDown 4.21%361.13M
BMYDown 0.62%82.81B
RHHBYUp 0.71%251.14B
SNYDown 0.57%147.24B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.61
Quarterly EPS Est (Sep-14) :-0.05
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback